News & Updates

Show Multimedia Only

Sivelestat helps mitigate ARDS risk in cardiovascular procedures

19 Mar 2026

Treatment with sivelestat in patients undergoing cardiovascular procedures appears to lower the incidence of acute respiratory distress syndrome (ARDS) and all-cause mortality, as reported in a study.

Sivelestat helps mitigate ARDS risk in cardiovascular procedures

19 Mar 2026

Original New Drug Application Approvals by US FDA (16-28 February 2026)

19 Mar 2026

New drug applications approved by US FDA as of 16-28 February 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-28 February 2026)

19 Mar 2026

Original New Drug Application Approvals by US FDA (1-15 March 2026)

19 Mar 2026

New drug applications approved by US FDA as of 1-15 March 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 March 2026)

19 Mar 2026

Bladder-sparing regimen for MIBC shows promising antitumour activity

18 Mar 2026 by

In the treatment of patients with muscle-invasive bladder cancer (MIBC), a perioperative regimen of the antibody–drug conjugate sacituzumab govitecan plus pembrolizumab yields a promising clinical complete response rate without eliciting grade ≥4 adverse events (AEs), allowing bladder preservation without further therapy in some patients, according to the phase II SURE-02 trial.

Bladder-sparing regimen for MIBC shows promising antitumour activity

18 Mar 2026

Smartwatch enhances AF detection in patients at risk of stroke

18 Mar 2026

The use of a smartwatch-based atrial fibrillation (AF) screening results in improved detection rates of new-onset AF relative to standard care in patients at increased risk of stroke, reports a study.

Smartwatch enhances AF detection in patients at risk of stroke

18 Mar 2026

Pemivibart prevents COVID-19 in people with advanced HIV

18 Mar 2026 by

Individuals living with advanced HIV infection who received pemivibart demonstrate good tolerability, with no cases of RT-PCR-confirmed symptomatic COVID-19 reported through month 6, as shown by the results of a subgroup analysis of the CANOPY study.

Pemivibart prevents COVID-19 in people with advanced HIV

18 Mar 2026

Viral load, ART regimen predict mortality in infants born to mothers living with HIV

18 Mar 2026 by

Several infants born to mothers living with HIV die within 50 weeks, and some of the factors that may contribute to infant death include lower maternal CD4 count, higher viral load, and maternal antiretroviral (ART) regimen, among others, suggests a study presented at CROI 2026.

Viral load, ART regimen predict mortality in infants born to mothers living with HIV

18 Mar 2026

Healthy lifestyle may sustain MetS remission post-treatment

18 Mar 2026

Promoting healthy habits through a behaviour-based lifestyle program helps keep metabolic syndrome (MetS) in remission after treatment, according to the Enhancing Lifestyles in Metabolic Syndrome (ELM) study.

Healthy lifestyle may sustain MetS remission post-treatment

18 Mar 2026

Vitamins linked to metabolic, mental health outcomes in Asian women

17 Mar 2026 by

Vitamin concentrations indicative of adequate nutrient intake appear to have a potential role in metabolic regulation and mental wellbeing in Asian women, according to local research.

Vitamins linked to metabolic, mental health outcomes in Asian women

17 Mar 2026

Mobile health tech helps improve weight, liver enzymes in NAFLD

17 Mar 2026

Mobile health (mHealth) technology interventions can support weight loss and even improve liver enzymes in patients with nonalcoholic fatty liver disease (NAFLD), suggest the results of a meta-analysis.

Mobile health tech helps improve weight, liver enzymes in NAFLD

17 Mar 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Sivelestat helps mitigate ARDS risk in cardiovascular procedures

Sivelestat helps mitigate ARDS risk in cardiovascular procedures

Original New Drug Application Approvals by US FDA (16-28 February 2026)

Original New Drug Application Approvals by US FDA (16-28 February 2026)

Original New Drug Application Approvals by US FDA (1-15 March 2026)

Original New Drug Application Approvals by US FDA (1-15 March 2026)

Bladder-sparing regimen for MIBC shows promising antitumour activity

Bladder-sparing regimen for MIBC shows promising antitumour activity

Smartwatch enhances AF detection in patients at risk of stroke

Smartwatch enhances AF detection in patients at risk of stroke

Pemivibart prevents COVID-19 in people with advanced HIV

Pemivibart prevents COVID-19 in people with advanced HIV

Viral load, ART regimen predict mortality in infants born to mothers living with HIV

Viral load, ART regimen predict mortality in infants born to mothers living with HIV

Healthy lifestyle may sustain MetS remission post-treatment

Healthy lifestyle may sustain MetS remission post-treatment

Vitamins linked to metabolic, mental health outcomes in Asian women

Vitamins linked to metabolic, mental health outcomes in Asian women

Mobile health tech helps improve weight, liver enzymes in NAFLD

Mobile health tech helps improve weight, liver enzymes in NAFLD